Literature DB >> 7608185

A novel glycosaminoglycan-binding protein is the vertebrate homologue of the cell cycle control protein, Cdc37.

N Grammatikakis1, A Grammatikakis, M Yoneda, Q Yu, S D Banerjee, B P Toole.   

Abstract

Using a monoclonal antibody, IVd4, that recognizes a novel group of hyaluronan-binding proteins, we have immunoscreened a cDNA library constructed from embryonic chick heart muscle mRNA. One of the cDNAs isolated from the library encodes a 29.3-kDa protein homologous to Cdc37, an essential cell cycle regulatory factor previously characterized genetically in yeast and Drosophila; this is the first vertebrate CDC37 gene to be cloned to date. We also present evidence for the existence of a second chick isoform that is identical to the 29.3-kDa protein over the first 175 amino acids but is entirely different at the carboxyl terminus and lacks the IVd4 epitope. The avian Cdc37 binds hyaluronan, chondroitin sulfate and heparin in vitro, and both isoforms contain glycosaminoglycan-binding motifs previously described in several hyaluronan-binding proteins. These findings suggest a role for glycosaminoglycans in cell division control.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7608185     DOI: 10.1074/jbc.270.27.16198

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  Intracellular proteoglycans.

Authors:  Svein Olav Kolset; Kristian Prydz; Gunnar Pejler
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

Review 2.  The endothelial glycocalyx: composition, functions, and visualization.

Authors:  Sietze Reitsma; Dick W Slaaf; Hans Vink; Marc A M J van Zandvoort; Mirjam G A oude Egbrink
Journal:  Pflugers Arch       Date:  2007-01-26       Impact factor: 3.657

3.  The oncoprotein kinase chaperone CDC37 functions as an oncogene in mice and collaborates with both c-myc and cyclin D1 in transformation of multiple tissues.

Authors:  L Stepanova; M Finegold; F DeMayo; E V Schmidt; J W Harper
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

Review 4.  Does DG42 synthesize hyaluronan or chitin?: A controversy about oligosaccharides in vertebrate development.

Authors:  A Varki
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

5.  A Role for HAPLN1 During Phenotypic Modulation of Human Lung Fibroblasts In Vitro.

Authors:  Stephen P Evanko; Michel D Gooden; Inkyung Kang; Christina K Chan; Robert B Vernon; Thomas N Wight
Journal:  J Histochem Cytochem       Date:  2020-10-16       Impact factor: 2.479

6.  CDC37 is required for p60v-src activity in yeast.

Authors:  B Dey; J J Lightbody; F Boschelli
Journal:  Mol Biol Cell       Date:  1996-09       Impact factor: 4.138

7.  Hyaluronan synthesis and myogenesis: a requirement for hyaluronan synthesis during myogenic differentiation independent of pericellular matrix formation.

Authors:  Liam C Hunt; Chris Gorman; Christopher Kintakas; Daniel R McCulloch; Eleanor J Mackie; Jason D White
Journal:  J Biol Chem       Date:  2013-03-14       Impact factor: 5.157

8.  Protumorigenic role of HAPLN1 and its IgV domain in malignant pleural mesothelioma.

Authors:  Alla V Ivanova; Chandra M V Goparaju; Sergey V Ivanov; Daisuke Nonaka; Christina Cruz; Amanda Beck; Fulvio Lonardo; Anil Wali; Harvey I Pass
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

9.  Development and validation of H11B2C2 monoclonal antibody-reactive hyaluronic acid binding protein: overexpression of HABP during human tumor progression.

Authors:  Rajeev K Boregowda; Hitesh N Appaiah; Mortha Karunakumar; Shivanna Parameshwariah; Geetha Avadani; Sunila Sunila; Shibdas Banerjee
Journal:  Tumour Biol       Date:  2012-10-26

10.  Inhibition of DNA topoisomerase I activity by heparan sulfate and modulation by basic fibroblast growth factor.

Authors:  I Kovalszky; J Dudás; J Oláh-Nagy; G Pogány; J Töváry; J Timár; L Kopper; A Jeney; R V Iozzo
Journal:  Mol Cell Biochem       Date:  1998-06       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.